Filing Details

Accession Number:
0001209191-16-123090
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-24 21:04:40
Reporting Period:
2016-05-23
Filing Date:
2016-05-24
Accepted Time:
2016-05-24 21:04:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411158 Anacor Pharmaceuticals Inc. ANAC Pharmaceutical Preparations (2834) 251854385
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1416180 R Keith Leonard C/O Anacor Pharmaceuticals, Inc.
1020 East Meadow Circle
Palo Alto CA 94303
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-23 9,000 $14.22 9,794 No 4 M Direct
Common Stock Disposition 2016-05-23 9,000 $99.70 794 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2016-05-23 9,000 $0.00 9,000 $14.22
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,000 2024-05-29 No 4 M Direct
Footnotes
  1. 1/3rd of the shares subject to the option shall vest and become exercisable in a series of three equal annual installments measured from May 29, 2014.